You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Drug Price Trends for NDC 60429-0321


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 60429-0321

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
DONEPEZIL HCL 5MG TAB Golden State Medical Supply, Inc. 60429-0321-10 1000 37.25 0.03725 2023-11-15 - 2028-06-14 FSS
DONEPEZIL HCL 5MG TAB Golden State Medical Supply, Inc. 60429-0321-30 30 1.78 0.05933 2023-11-15 - 2028-06-14 FSS
DONEPEZIL HCL 5MG TAB Golden State Medical Supply, Inc. 60429-0321-90 90 4.00 0.04444 2023-11-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

60429-0321 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 60429-0321: Donepezil Hydrochloride

Overview of Donepezil Hydrochloride

Donepezil Hydrochloride, identified by the National Drug Code (NDC) 60429-0321, is a medication primarily used in the treatment of Alzheimer's disease. It belongs to the class of cholinesterase inhibitors, which work by increasing the concentration of acetylcholine in the brain, thereby improving cognitive function.

Market Context

Global Pharmaceutical Market Trends

The pharmaceutical industry, particularly the segment dealing with neurological disorders, is expected to see significant growth driven by advances in technology and increasing demand for effective treatments. According to Deloitte's 2025 life sciences outlook, the industry is poised for transformation due to digital advancements and scientific innovations[3].

Specific Market for Donepezil Hydrochloride

Donepezil Hydrochloride is a well-established drug in the market for Alzheimer's treatment. Here are some key points to consider:

Competition from Generics

The market for Donepezil Hydrochloride is subject to competition from generic versions, which can impact pricing. As patents expire, generic drugs and biosimilars become more prevalent, affecting the pricing strategies of original manufacturers. For instance, 37% of life sciences executives view competition from generic drugs as a top trend[3].

Pricing and Access

Pricing and access to drugs are significant issues in the life sciences industry. Nearly half of the C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025. This trend could influence the pricing of Donepezil Hydrochloride, especially as generic versions become more available[3].

Current Pricing and Availability

NDC 60429-0321 Specifics

The NDC 60429-0321 is associated with Golden State Medical Supply, Inc. However, the specific pricing details for this NDC are not provided in the available sources. Generally, the prices of pharmaceuticals can vary based on factors such as the manufacturer, distributor, and regulatory environment.

Pricing Trends

For similar medications, pricing can be influenced by market dynamics, regulatory changes, and the introduction of new treatments. For example, the Missouri Specialty MAC list provides pricing for various drugs effective January 1, 2023, but does not include specific pricing for NDC 60429-0321[2].

Price Projections

Impact of Generic Competition

Given the increasing competition from generic drugs, the price of Donepezil Hydrochloride is likely to decrease over time. As more generic versions enter the market, the pricing pressure on branded and original formulations tends to increase, leading to potential price reductions.

Market Growth and Demand

Despite the competition, the demand for Alzheimer's treatments is expected to grow due to an aging population and the increasing prevalence of the disease. This demand could stabilize prices to some extent, although the overall trend is likely to be downward due to generic competition.

Regulatory and Economic Factors

Regulatory changes, reimbursement policies, and economic conditions also play a significant role in pricing. For instance, changes in healthcare policies or reimbursement rates can affect the pricing strategy of pharmaceutical companies[3].

Key Takeaways

  • Generic Competition: The presence of generic versions of Donepezil Hydrochloride is expected to drive down prices.
  • Market Demand: Increasing demand for Alzheimer's treatments may stabilize prices but is unlikely to counteract the downward pressure from generics.
  • Regulatory and Economic Factors: Changes in healthcare policies, reimbursement rates, and economic conditions will influence pricing strategies.
  • Technological Advancements: Advances in technology and innovation in the life sciences sector may lead to new treatments, potentially affecting the market for existing drugs like Donepezil Hydrochloride.

FAQs

What is Donepezil Hydrochloride used for?

Donepezil Hydrochloride is primarily used in the treatment of Alzheimer's disease to improve cognitive function.

How does Donepezil Hydrochloride work?

It works by increasing the concentration of acetylcholine in the brain, thereby improving cognitive function.

What is the impact of generic competition on the price of Donepezil Hydrochloride?

Generic competition is likely to drive down the price of Donepezil Hydrochloride as more generic versions enter the market.

What are the key factors influencing the price of Donepezil Hydrochloride?

Key factors include generic competition, market demand, regulatory changes, and economic conditions.

How is the pharmaceutical industry expected to evolve in the coming years?

The industry is expected to see significant transformation driven by digital advancements, scientific innovations, and increasing demand for personalized and effective treatments[3].

Sources

  1. Find-A-Code: Golden State Medical Supply - NDC products[1]
  2. Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023[2]
  3. Deloitte Insights: 2025 life sciences outlook[3]
  4. BCC Research: Biologic Therapeutic Drugs: Technologies and Global Markets[4]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.